Balaji Amines Ltd
About
Balaji Amines Limited (BAL) has been specialising in the production of derivatives of specialty chemicals and pharmaceutical excipients, in addition to methyl amines and ethyl amines, since 1988. Balaji also manufactures the derivatives of these products for the pesticides and pharmaceutical industries on a need basis. BAL is majorly based out of Solapur in Maharashtra, in and around which three of its four manufacturing facilities are located. The facility in Tamalwadi, Solapur, is equipped with computerised control systems and an R&D laboratory that facilitates the adoption and invention of the latest technology in the industry. The other manufacturing facility is situated in Hyderabad. With the help of these facilities, BAL is able to export to 23 countries, including Brazil, the US, the UK, Korea, South Africa, and Bangladesh, among others.
Featured In Fortune India Ranking
Financial Data 2024
Financial Data
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 1684 -29.4% | 2386 -0.2% | 2391 83.5% | 1303 40.9% | 925 -4.9% | 973 11.8% | 870 27.1% | 685 10.4% | 620 0.0% | 620 -2.4% | 635 29.5% | 490 4.0% | 472 27.2% | 371 39.2% | 266 4.5% | 255 - |
| Net Operating Income (INR Cr) | 1642 -30.31% | 2355 1.40% | 2323 77.12% | 1311 40.15% | 936 -0.77% | 943 9.50% | 861 28.45% | 670 4.25% | 643 3.94% | 619 1.42% | 610 19.21% | 512 13.85% | 450 29.63% | 347 32.41% | 262 4.06% | 252 15.55% |
| Profit (INR Cr) | 205 -37.1% | 326 -11.6% | 368 54.7% | 238 127.3% | 105 -10.8% | 118 3.8% | 113 37.4% | 82 42.9% | 58 73.5% | 33 -0.9% | 34 7.5% | 31 -12.5% | 36 34.0% | 27 30.2% | 20 35.6% | 15 - |
| Assets (INR Cr) | 1919 9.1% | 1760 23.9% | 1420 34.1% | 1058 12.1% | 945 13.0% | 836 28.5% | 650 37.4% | 473 1.8% | 465 -7.4% | 502 7.3% | 468 21.0% | 387 6.0% | 365 31.2% | 278 48.0% | 188 9.6% | 171 - |
| Net Worth (INR Cr) | 1722 10.8% | 1554 24.4% | 1250 39.7% | 894 35.9% | 658 14.6% | 574 23.0% | 467 28.9% | 362 29.4% | 280 23.0% | 228 13.3% | 201 17.4% | 171 18.1% | 145 29.0% | 112 27.6% | 88 26.6% | 70 24.2% |
| Employee Cost (INR Cr) | 82 -3.5% | 85 -11.8% | 97 188.0% | 34 -1.5% | 34 15.6% | 29 9.6% | 27 9.9% | 24 13.1% | 22 3.5% | 21 31.9% | 16 22.8% | 13 8.4% | 12 22.2% | 10 37.0% | 7 23.9% | 6 - |
| Interest Cost (INR Cr) | 6 | 12 | 17 | 18 | 23 | 13 | 9 | 13 | 22 | 35 | 32 | 25 | 21 | 14 | 10 | 10 |
| Cash & Bank Balance (INR Cr) | 340 | 236 | 52 | 20 | 9 | 20 | 24 | 3 | 9 | 7 | 10 | 3 | 4 | 9 | 4 | 2 |
| Total Debt (INR Cr) | 20 | 58 | 101 | 127 | 260 | 227 | 152 | 105 | 173 | 256 | 262 | 209 | 216 | 165 | 100 | 102 |
Key Financial Ratios
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 12.2% | 13.6% | 15.4% | 18.3% | 11.3% | 12.1% | 13.0% | 12.0% | 9.3% | 5.4% | 5.3% | 6.4% | 7.6% | 7.2% | 7.7% | 5.9% |
| Profit As % Of Assets | 10.7% | 18.5% | 26.0% | 22.5% | 11.1% | 14.1% | 17.4% | 17.4% | 12.4% | 6.6% | 7.2% | 8.1% | 9.8% | 9.6% | 10.9% | 8.8% |
| Profit As % Of Networth | 11.9% | 20.9% | 29.5% | 26.6% | 15.9% | 20.5% | 24.2% | 22.7% | 20.6% | 14.6% | 16.7% | 18.2% | 24.6% | 23.6% | 23.2% | 21.6% |
| Interest Cost to EBITDA % | 2.0% | 2.0% | 2.8% | 4.9% | 12.7% | 6.7% | 5.0% | 8.7% | 17.5% | 34.3% | 34.6% | 31.6% | 26.3% | 21.5% | 21.1% | 27.7% |
| Debt to Equity Ratio | 0.01 | 0.04 | 0.08 | 0.14 | 0.39 | 0.40 | 0.33 | 0.29 | 0.62 | 1.12 | 1.30 | 1.22 | 1.49 | 1.47 | 1.13 | 1.46 |
| RONW | 14.2% | 28.9% | 39.0% | 31.4% | 15.8% | 22.5% | 27.3% | 25.6% | 22.7% | 15.5% | 18.0% | 19.7% | 27.7% | 26.5% | 25.9% | 24.0% |
| ROCE | 18.3% | 39.0% | 49.7% | 34.9% | 17.6% | 24.6% | 31.6% | 29.6% | 22.8% | 17.8% | 18.1% | 19.0% | 23.0% | 24.3% | 22.9% | 22.5% |